This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vázquez, N.
Right arrow Articles by Lyman, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez, N.
Right arrow Articles by Lyman, C. A.

 Previous Article  |  Next Article 

Infect. Immun., 01 1998, 145-150, Vol 66, No. 1
Copyright © 1998, American Society for Microbiology

Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans

N Vazquez, TJ Walsh, D Friedman, SJ Chanock and CA Lyman
Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

Interleukin-15 (IL-15) is a newly described cytokine that shares biological activities with IL-2. We report here results demonstrating the ability of IL-15 to enhance superoxide production and antifungal activity of human monocytes. After 18 and 48 h of treatment with IL-15, human elutriated monocytes manifested enhanced superoxide production in response to either phorbol myristate acetate or opsonized Candida albicans blastoconidia. Similar results were obtained when monocytes were treated with IL-2, but to a lesser extent. Combination studies with IL-15 and IL-2 showed no additive or synergistic effects. Following incubation of monocytes with IL-15 for 18 h, there was no significant increase in mRNA transcripts for components of the NADPH oxidase complex, p40-phox, p47-phox, and gp91-phox, suggesting a posttranscriptional modulation of enhanced superoxide production. Antibodies against the gamma chain of the IL-2 receptor and, to a lesser extent, against the beta chain partially abrogated the IL-15- mediated enhanced superoxide production. Additionally, human monocytes showed enhanced killing activity against C. albicans after 18 h of incubation with IL-15 or IL-2, but this treatment did not enhance the ability of these cells to phagocytose the organism. In addition, the enhanced fungicidal activity seen after 18 h of treatment was no longer detectable after 48 h of cytokine treatment. Culture supernatants from the IL-15-treated monocytes were assayed for the presence of other proinflammatory cytokines. IL-15 treatment did not induce the release of detectable levels of tumor necrosis factor alpha, IL-1beta, or IL- 12. Our results indicate that IL-15 upregulates the microbicidal activity of human monocytes against C. albicans.


This article has been cited by other articles:

  • Krutzik, S. R., Hewison, M., Liu, P. T., Robles, J. A., Stenger, S., Adams, J. S., Modlin, R. L. (2008). IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway. J. Immunol. 181: 7115-7120 [Abstract] [Full Text]  
  • Segal, B. H., Walsh, T. J. (2006). Current Approaches to Diagnosis and Treatment of Invasive Aspergillosis. Am. J. Respir. Crit. Care Med. 173: 707-717 [Abstract] [Full Text]  
  • Kim, H. S., Choi, E. H., Khan, J., Roilides, E., Francesconi, A., Kasai, M., Sein, T., Schaufele, R. L., Sakurai, K., Son, C. G., Greer, B. T., Chanock, S., Lyman, C. A., Walsh, T. J. (2005). Expression of Genes Encoding Innate Host Defense Molecules in Normal Human Monocytes in Response to Candida albicans. Infect. Immun. 73: 3714-3724 [Abstract] [Full Text]  
  • de Groot, P. W. J., de Boer, A. D., Cunningham, J., Dekker, H. L., de Jong, L., Hellingwerf, K. J., de Koster, C., Klis, F. M. (2004). Proteomic Analysis of Candida albicans Cell Walls Reveals Covalently Bound Carbohydrate-Active Enzymes and Adhesins. Eukaryot Cell 3: 955-965 [Abstract] [Full Text]  
  • Neely, G. G., Epelman, S., Ma, L. L., Colarusso, P., Howlett, C. J., Amankwah, E. K., McIntyre, A. C., Robbins, S. M., Mody, C. H. (2004). Monocyte Surface-Bound IL-15 Can Function as an Activating Receptor and Participate in Reverse Signaling. J. Immunol. 172: 4225-4234 [Abstract] [Full Text]  
  • Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A., Watanabe, N. (2002). Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect. Antimicrob. Agents Chemother. 46: 3113-3117 [Abstract] [Full Text]  
  • Lamarre, C., LeMay, J.-D., Deslauriers, N., Bourbonnais, Y. (2001). Candida albicans Expresses an Unusual Cytoplasmic Manganese-containing Superoxide Dismutase (SOD3 Gene Product) upon the Entry and during the Stationary Phase. J. Biol. Chem. 276: 43784-43791 [Abstract] [Full Text]  
  • Mattei, F., Schiavoni, G., Belardelli, F., Tough, D. F. (2001). IL-15 Is Expressed by Dendritic Cells in Response to Type I IFN, Double-Stranded RNA, or Lipopolysaccharide and Promotes Dendritic Cell Activation. J. Immunol. 167: 1179-1187 [Abstract] [Full Text]  
  • Umemura, M., Nishimura, H., Hirose, K., Matsuguchi, T., Yoshikai, Y. (2001). Overexpression of IL-15 In Vivo Enhances Protection Against Mycobacterium bovis Bacillus Calmette-Guerin Infection Via Augmentation of NK and T Cytotoxic 1 Responses. J. Immunol. 167: 946-956 [Abstract] [Full Text]  
  • Mastroianni, C. M., d'Ettorre, G., Forcina, G., Lichtner, M., Mengoni, F., D'Agostino, C., Corpolongo, A., Massetti, A. P., Vullo, V. (2000). Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood 96: 1979-1984 [Abstract] [Full Text]  
  • Dodd-O, J. M., Pearse, D. B. (2000). Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am. J. Physiol. Heart Circ. Physiol. 279: H303-H312 [Abstract] [Full Text]  
  • Maeurer, M. J., Trinder, P., Hommel, G., Walter, W., Freitag, K., Atkins, D., Storkel, S. (2000). Interleukin-7 or Interleukin-15 Enhances Survival of Mycobacterium tuberculosis-Infected Mice. Infect. Immun. 68: 2962-2970 [Abstract] [Full Text]  
  • Nishimura, H., Yajima, T., Naiki, Y., Tsunobuchi, H., Umemura, M., Itano, K., Matsuguchi, T., Suzuki, M., Ohashi, P. S., Yoshikai, Y. (2000). Differential Roles of Interleukin 15 mRNA Isoforms Generated by Alternative Splicing in Immune Responses in Vivo. JEM 191: 157-170 [Abstract] [Full Text]  
  • Musso, T., Calosso, L., Zucca, M., Millesimo, M., Ravarino, D., Giovarelli, M., Malavasi, F., Ponzi, A. N., Paus, R., Bulfone-Paus, S. (1999). Human Monocytes Constitutively Express Membrane-Bound, Biologically Active, and Interferon-{gamma}-Upregulated Interleukin-15. Blood 93: 3531-3539 [Abstract] [Full Text]  
  • Musso, T., Calosso, L., Zucca, M., Millesimo, M., Puliti, M., Bulfone-Paus, S., Merlino, C., Savoia, D., Cavallo, R., Ponzi, A. N., Badolato, R. (1998). Interleukin-15 Activates Proinflammatory and Antimicrobial Functions in Polymorphonuclear Cells. Infect. Immun. 66: 2640-2647 [Abstract] [Full Text]